IRIS

CERRI, SILVIA

CERRI, SILVIA  

DIPARTIMENTO DI BIOLOGIA ANIMALE (attivo dal 01/01/1900 al 31/12/2011)  

Mostra records
Risultati 1 - 20 di 48 (tempo di esecuzione: 0.037 secondi).
Titolo Data di pubblicazione Autore(i) File
A further update on the role of excitotoxicity in the pathogenesis of Parkinson’s disease 1-gen-2014 Ambrosi, G.; Cerri, S.; Blandini, F.
Activation of the CREB/c-Fos Pathway during Long-Term Synaptic Plasticity in the Cerebellum Granular Layer 1-gen-2017 Gandolfi, Daniela; Cerri, Silvia; Mapelli, Jonathan; Polimeni, Mariarosa; Tritto, Simona; Fuzzati Armentero, Marie Therese; Bigiani, Albertino; Blandini, Fabio; Mapelli, Lisa; D'Angelo, EGIDIO UGO
Activation of the DNA damage response in vivo in synucleinopathy models of Parkinson’s disease 1-gen-2018 Milanese, C.; Cerri, S.; Ulusoy, A.; Gornati, S. V.; Plat, A.; Gabriels, S.; Blandini, F.; Di Monte, D. A.; Hoeijmakers, J. H.; Mastroberardino, P. G.
Activation of the DNA damage response in vivo in synucleinopathy models of Parkinson’s disease 1-gen-2018 Milanese, C.; Cerri, S.; Ulusoy, A.; Gornati, S. V.; Plat, A.; Gabriels, S.; Blandini, F.; Di Monte, D. A.; Hoeijmakers, J. H.; Mastroberardino, P. G.
Adhesion molecules as potential targets for neuroprotection in a rodent model of Parkinson's disease 1-gen-2011 Armentero, M. -T.; Levandis, G.; Bazzini, E.; Cerri, S.; Ghezzi, C.; Blandini, F.
Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration 1-gen-2016 Pellegrini, C.; Fornai, M.; Colucci, R.; Tirotta, E.; Blandini, F.; Levandis, G.; Cerri, S.; Segnani, C.; Ippolito, C.; Bernardini, N.; Cseri, K.; Blandizzi, C.; Hasko, G.; Antonioli, L.
Ambroxol as a disease-modifying treatment to reduce the risk of cognitive impairment in GBA-associated Parkinson's disease: a multicentre, randomised, double-blind, placebo-controlled, phase II trial. The AMBITIOUS study protocol 1-gen-2023 Colucci, Fabiana; Avenali, Micol; De Micco, Rosita; Fusar Poli, Marco; Cerri, Silvia; Stanziano, Mario; Bacila, Ana; Cuconato, Giada; Franco, Valentina; Franciotta, Diego; Ghezzi, Cristina; Gastaldi, Matteo; Elia, Antonio Emanuele; Romito, Luigi; Devigili, Grazia; Leta, Valentina; Garavaglia, Barbara; Golfrè Andreasi, Nico; Cazzaniga, Federico; Reale, Chiara; Galandra, Caterina; Germani, Giancarlo; Mitrotti, Pierfrancesco; Ongari, Gerardo; Palmieri, Ilaria; Picascia, Marta; Pichiecchio, Anna; Verri, Mattia; Esposito, Fabrizio; Cirillo, Mario; Di Nardo, Federica; Aloisio, Simone; Siciliano, Mattia; Prioni, Sara; Amami, Paolo; Piacentini, Sylvie; Bruzzone, Maria Grazia; Grisoli, Marina; Moda, Fabio; Eleopra, Roberto; Tessitore, Alessandro; Valente, Enza Maria; Cilia, Roberto
An update on the use of non-ergot dopamine agonists for the treatment of Parkinson’s disease 1-gen-2020 Cerri, S.; Blandini, F.
Cell proliferation and death in the brain of active and hibernating frogs 1-gen-2009 Cerri, Silvia; Bottiroli, G.; Bottone, MARIA GRAZIA; Barni, Sergio; Bernocchi, Graziella
Complex Changes in the Innate and Adaptive Immunity Accompany Progressive Degeneration of the Nigrostriatal Pathway Induced by Intrastriatal Injection of 6-Hydroxydopamine in the Rat 1-gen-2017 Ambrosi, G.; Kustrimovic, N.; Siani, F.; Rasini, E.; Cerri, S.; Ghezzi, C.; Dicorato, G.; Caputo, S.; Marino, F.; Cosentino, M.; Blandini, F.
Development and biochemical characterization of a mouse model of Parkinson's disease bearing defective glucocerebrosidase activity 1-gen-2019 Mus, L.; Siani, F.; Giuliano, C.; Ghezzi, C.; Cerri, S.; Blandini, F.
Developmental neurotoxicity study of platinum compounds. Effects of cisplatin versus a novel Pt(II) complex on rat cerebellum 1-gen-2011 Cerri, Silvia; Piccolini, VALERIA MARIA; Santin, Giada; Bottone, MARIA GRAZIA; De Pascali, S. A.; Migoni, D.; Iadarola, Paolo; Fanizzi, F. P.; Bernocchi, Graziella
Dual target strategy: Combining distinct non-dopaminergic treatments reduces neuronal cell loss and synergistically modulates l -DOPA-induced rotational behavior in a rodent model of Parkinson's disease 1-gen-2015 Fuzzati-Armentero, M. -T.; Cerri, S.; Levandis, G.; Ambrosi, G.; Montepeloso, E.; Antoninetti, G.; Blandini, F.; Baqi, Y.; Muller, C. E.; Volpini, R.; Costa, G.; Simola, N.; Pinna, A.
Effects of cisplatin on neuronal cell B50: involvement of mitochondria in apoptosis induction. 1-gen-2006 Avella, Debora; Soldani, Cristiana; Bottone, MARIA GRAZIA; Veneroni, Paola; Pisu Maria, Bonaria; Cerri, Silvia; Bernocchi, Graziella
Effects of L-DOPA/benserazide co-treatment on colonic excitatory cholinergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration 1-gen-2017 Pellegrini, C.; Antonioli, L.; Colucci, R.; Tirotta, E.; Gentile, D.; Ippolito, C.; Segnani, C.; Levandis, G.; Cerri, S.; Blandini, F.; Barocelli, E.; Ballabeni, V.; Bernardini, N.; Blandizzi, C.; Fornai, M.
Gba mutations influence the release and pathological effects of small extracellular vesicles from fibroblasts of patients with parkinson’s disease 1-gen-2021 Cerri, S.; Ghezzi, C.; Ongari, G.; Croce, S.; Avenali, M.; Zangaglia, R.; Di Monte, D. A.; Valente, E. M.; Blandini, F.
Gender biased neuroprotective effect of Transferrin Receptor 2 deletion in multiple models of Parkinson’s disease 1-gen-2020 Milanese, C.; Gabriels, S.; Barnhoorn, S.; Cerri, S.; Ulusoy, A.; Gornati, S. V.; Wallace, D. F.; Blandini, F.; Di Monte, D. A.; Subramaniam, V. N.; Mastroberardino, P. G.
Glucocerebrosidase Defects as a Major Risk Factor for Parkinson’s Disease 1-gen-2020 Avenali, M.; Blandini, F.; Cerri, S.
Glucocerebrosidase mutations and synucleinopathies: Toward a model of precision medicine 1-gen-2019 Blandini, F.; Cilia, R.; Cerri, S.; Pezzoli, G.; Schapira, A. H. V.; Mullin, S.; Lanciego, J. L.
Immediate early genes regulation in rat cerebellar cortex during long-term synaptic plasticity induction. 1-gen-2011 Polimeni, Mariarosa; Gandolfi, Daniela; Cerri, Silvia; Mapelli, Jonathan; Tritto, Simona; Alloni, Maurizio; Armentero, M. T.; Blandini, Fabio; D'Angelo, EGIDIO UGO